Display Settings:

Format

Send to:

Choose Destination
    Trends Pharmacol Sci. 2006 Sep;27(9):458-60. Epub 2006 Jul 25.

    GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor.

    Source

    Departments of Anesthesiology and Critical Care Medicine, and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. sdore@jhmi.edu

    Abstract

    A recent article supports the concept that prostaglandin (PG)E(2) EP(1)-receptor antagonists reduce stroke severity and cell damage; could these agents become a substitute for cyclooxygenase (COX)-2 inhibitors? The total activity of COXs--rate-limiting enzymes of PGE(2) synthesis--increases following acute neurological insult. Drugs that offer the beneficial anti-inflammatory and neuroprotective effects of PGs but that limit the negative effects of COX-2 inhibition could provide the next generation of treatment for acute neuronal damage.

    PMID:
    16870271
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk